NETRAMARK HOLDINGS INC (AIAI.CA) Stock Price & Overview
TSX:AIAI • CA64119M1059
The current stock price of AIAI.CA is 1.1 CAD. Today AIAI.CA is up by 11.11%.
AIAI.CA Key Statistics
- Market Cap
- 101.013M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -0.07
- Dividend Yield
- N/A
AIAI.CA Stock Performance
AIAI.CA Stock Chart
AIAI.CA Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to AIAI.CA.
AIAI.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to AIAI.CA. While AIAI.CA has a great health rating, there are worries on its profitability.
AIAI.CA Earnings
AIAI.CA Forecast & Estimates
AIAI.CA Groups
Sector & Classification
AIAI.CA Financial Highlights
Over the last trailing twelve months AIAI.CA reported a non-GAAP Earnings per Share(EPS) of -0.07. The EPS decreased by -50.32% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -376.97% | ||
| ROE | -489.96% | ||
| Debt/Equity | 0 |
AIAI.CA Ownership
AIAI.CA Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| VHI | VITALHUB CORP | 32.4 | 526.074M | ||
| NURS | HYDREIGHT TECHNOLOGIES INC | 8.35 | 143.058M | ||
| ADK | DIAGNOS INC | N/A | 35.521M | ||
| KDA | KDA GROUP INC | N/A | 25.006M | ||
| AVCR | AVRICORE HEALTH INC | N/A | 7.09M | ||
| EKG | CARDIOCOMM SOLUTIONS INC | N/A | 1.976M | ||
| KOVO | KOVO+ HOLDINGS INC | N/A | 1.769M |
Related stock screener links
View all stocks in the Health Care Technology Industry | View all stocks in the Health Care Sector | View all stocks on the Toronto Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the Canadian exchanges | Find stocks with similar Fundamental rating on the Canadian exchanges | Find the competitors with the best technical ratings on the Canadian exchanges | Find the competitors with the best fundamentals on the Canadian exchanges | Find the competitors with the best valuation on the Canadian exchanges | Find the competitors with the best dividend on the Canadian exchanges | Find the competitors with the best analyst ratings on the Canadian exchanges
About AIAI.CA
Company Profile
NetraMark Holdings, Inc. engages in the development of artificial intelligence and machine learning solutions. The company is headquartered in Toronto, Ontario. The company went IPO on 2021-06-08. The Company’s product offering uses a novel topology-based algorithm that has the ability to parse patient data sets into subsets of people that are strongly related according to several variables simultaneously. This allows the Company to use a variety of ML methods, depending on the character and size of the data, to transform the data into powerfully intelligent data that activates traditional AI/ML methods. The result is that it can work with smaller datasets and accurately segment diseases into different types, as well as accurately classify patients for sensitivity to drugs and/or efficacy of treatment. The typical molecular data used is RNASeq, microarray, single nucleotide polymorphism (SNP) and methylation.
Company Info
IPO: 2021-06-08
NETRAMARK HOLDINGS INC
Suite 101 - 1655 Dupont Street
TORONTO ONTARIO CA
Employees: 0
Phone: 16472237165
NETRAMARK HOLDINGS INC / AIAI.CA FAQ
Can you describe the business of NETRAMARK HOLDINGS INC?
NetraMark Holdings, Inc. engages in the development of artificial intelligence and machine learning solutions. The company is headquartered in Toronto, Ontario. The company went IPO on 2021-06-08. The Company’s product offering uses a novel topology-based algorithm that has the ability to parse patient data sets into subsets of people that are strongly related according to several variables simultaneously. This allows the Company to use a variety of ML methods, depending on the character and size of the data, to transform the data into powerfully intelligent data that activates traditional AI/ML methods. The result is that it can work with smaller datasets and accurately segment diseases into different types, as well as accurately classify patients for sensitivity to drugs and/or efficacy of treatment. The typical molecular data used is RNASeq, microarray, single nucleotide polymorphism (SNP) and methylation.
What is the current price of AIAI stock?
The current stock price of AIAI.CA is 1.1 CAD. The price increased by 11.11% in the last trading session.
What is the dividend status of NETRAMARK HOLDINGS INC?
AIAI.CA does not pay a dividend.
How is the ChartMill rating for NETRAMARK HOLDINGS INC?
AIAI.CA has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
Can you provide the PE ratio for AIAI stock?
NETRAMARK HOLDINGS INC (AIAI.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.07).
Can you provide the number of employees for NETRAMARK HOLDINGS INC?
NETRAMARK HOLDINGS INC (AIAI.CA) currently has 0 employees.